Furosemide (Lasix) Intravenous Infusion Dosing
For hospitalized patients with acute decompensated heart failure, furosemide IV infusion should be dosed at 5-20 mg/hour (maximum 40 mg/hour), with the starting rate determined by prior oral diuretic exposure: use 1-2.5 times the home oral dose for diuretic-experienced patients, or start at the lower end (5 mg/hour) for diuretic-naïve patients. 1
Dosing Algorithm
Initial Dose Selection
Diuretic-experienced patients: Convert home oral dose to IV at 1-2.5 times the oral dose, then divide for continuous infusion rate
- Example: Patient on 80 mg oral furosemide daily → Start 10-20 mg/hour IV infusion 1
Diuretic-naïve patients: Start with 20-40 mg IV bolus or 5 mg/hour continuous infusion 2, 3
Infusion vs. Bolus Dosing
Both continuous infusion and intermittent bolus dosing (40-160 mg IV every 12 hours) are equally effective - there is no significant difference in symptom improvement or renal function changes between the two methods 4. The 2019 ACC guidelines present both as equivalent options 1.
However, the practical considerations differ:
- Continuous infusion advantages: More stable urine output with less fluctuation, potentially lower total drug requirement, and reduced electrolyte losses 5, 6
- Bolus dosing advantages: Simpler administration, no need for infusion pump
Dose Titration
- Assess response at 2 hours: Urine output at 2 hours reliably predicts adequacy and need for dose adjustment 7
- Target urine output: Aim for adequate diuresis (typically >1 mL/kg/hour initially)
- Dose escalation: If inadequate response, double the infusion rate every 2 hours up to maximum 40 mg/hour 1
- Maximum dosing: Can titrate up to 600 mg/day in severe edematous states 3
Monitoring Requirements
Daily monitoring is mandatory 1:
- Electrolytes (especially potassium, sodium)
- Serum creatinine and BUN
- Daily weights
- Intake and output
- Clinical assessment of congestion (JVP, edema, orthopnea)
Important Caveat on Creatinine
A slight rise in serum creatinine during effective decongestion is common and expected, typically returns to baseline after discharge, and is not associated with worse outcomes 1. Do not reflexively stop diuretics for mild creatinine elevation if decongestion is ongoing.
High-Dose vs. Low-Dose Strategy
The DOSE trial 4 showed that a high-dose strategy (2.5 times home dose) trended toward better symptom improvement without significant difference in renal function compared to low-dose strategy. High-dose was associated with:
- Greater total diuresis
- More favorable secondary outcomes
- Transient worsening of renal function (clinically insignificant)
For patients with refractory congestion, escalate to high-dose strategy rather than accepting inadequate diuresis.
Refractory Cases
If inadequate response despite maximum furosemide infusion 1:
- Add thiazide-type diuretic (metolazone 2.5-5 mg orally, chlorothiazide 0.5-1 g IV)
- Consider IV vasodilators (nitroglycerin, nitroprusside) if congestive symptoms persist
- Ultrafiltration or hemodialysis as last resort (though trials show no outcome benefit) 1
Safety Considerations
- Avoid in hypotension or hypoperfusion without addressing hemodynamics first 2
- Continue evidence-based HF medications (ACE-I/ARB, beta-blockers) unless hemodynamically unstable 2
- Electrolyte replacement: Correct hypokalemia and hypomagnesemia proactively
- Geriatric patients: Start at lower end of dosing range 3